Top Story

Test Tube Liquid Sample Social
Agreement
BioMĂ©rieux subsidiary secures DoD contract for infectious disease testing system
BioFire Defense, a subsidiary of BioMĂ©rieux, has secured an order-dependent contract with the U.S. Department of Defense (DoD) to provide support for a military-use version of its multiplex polymerase chain reaction infectious disease test system.
Featured
Cigarette Smoking Social
Schizophrenia
Genetic predisposition to smoking may drive schizophrenia heart disease risk: Study
Artificial Intelligence Drug Design Funding Social
Financing
Harbinger Health raises $140M in series B funding
Latest News
Plasmodium Falciparum Malaria Cdc Social
Study shows malaria drug resistance occurring in Horn of Africa
September 29, 2023
Latest in at-home or lab-based STI testing
Sponsored
Latest in at-home or lab-based STI testing
September 28, 2023
Gavel Money Social
U.S. Attorney’s Office wins $370M judgment in Medicare fraud case
September 28, 2023
Rna Strand Social
Ginkgo Bioworks, Pfizer collaborate on RNA-based therapeutics
September 28, 2023
Test Tube Liquid Sample Social
Agreement
BioMĂ©rieux subsidiary secures DoD contract for infectious disease testing system
Kickback
U.S. Attorney’s Office wins $370M judgment in Medicare fraud case
Collaboration
Ginkgo Bioworks, Pfizer collaborate on RNA-based therapeutics
Technology Development
Thermo Fisher Scientific prepared to expand its work at manufacturing facility
Kidney Social
Artificial Intelligence
AI model reveals kidney tumor features, potential for treatment response prediction
Breast Cancer
Consumer genetic testing may misrepresent breast cancer risk: Study
Financing
Rome Therapeutics raises $72M in series B financing
Informatics
Many British health trusts slow to adopt electronic records systems, shows BMJ survey
Dna Sequencing2
Antibiotic Resistance
Day Zero Diagnostics to use $16M in funding to improve management of antibiotic-resistant infections
COVID-19
Study launched on early intervention with immune modulators in COVID-19
COVID-19
U.S. government investing $600M in COVID-19 test manufacturing
Sepsis
Some emergency sepsis screening tools inadequate, EU study suggests
More from LabPulse.com
Study launched on early intervention with immune modulators in COVID-19
A clinical trial has been launched to determine if there are benefits to early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness.
September 26, 2023
Coronavirus Covid Blue Social
U.S. government investing $600M in COVID-19 test manufacturing
The U.S. Department of Health and Human Services announced that it is investing $600 million in funding into COVID-19 test manufacturing.
September 26, 2023
Dollar Money Coronavirus Mask Social
Some emergency sepsis screening tools inadequate, EU study suggests
Two out of the four internationally recommended screening tools used by emergency medical services are inadequate for recognizing sepsis, say German researchers.
September 26, 2023
Sepsis Bacteria Social
Thermo Fisher Scientific prepared to expand its work at manufacturing facility
Thermo Fisher Scientific executives voiced hopes for expanding work to help combat diseases at its giant $180 million viral vector manufacturing site in Plainville, MA.
September 27, 2023
Manufacturing Facility Process Social
HIV vaccine trial begins enrollment in U.S., South Africa
A clinical trial for a preventive HIV vaccine has begun enrollment in both the U.S. and South Africa.
September 25, 2023
Vial Vaccine Vial Tech Social
Alzheimer’s drug approval poised to reshape APOE testing market
The U.S. Food and Drug Administration (FDA) approval of Biogen and Eisai’s Alzheimer’s disease drug Leqembi is likely to drive changes in the APOE testing market, according to an article in GenomeWeb.
September 25, 2023
Amyloid Plaque Alzheimer Social
Invitae receives noncompliance notice from NYSE
San Francisco-based medical genetics company Invitae received a notice of noncompliance from the New York Stock Exchange (NYSE) on September 20 for its stock price closing under $1.00 per share for 30 consecutive days.
September 25, 2023
Business Graph Money Stocks Social
AI model reveals kidney tumor features, potential for treatment response prediction
Researchers at the Dana-Farber Cancer Institute have trained artificial intelligence (AI) models to assess the clinical features of kidney cancer tumor samples to predict how tumors may respond to immune therapy.
September 22, 2023
Kidney Social
Consumer genetic testing may misrepresent breast cancer risk: Study
Women are being told they are at high risk of breast cancer from consumer genetic test results which do not take family history into account, say researchers.
September 21, 2023
Breast Cancer3 Social
Rome Therapeutics raises $72M in series B financing
Biotech company Rome Therapeutics has raised a further $72 million in financing to develop medicines for autoimmune diseases and continue its exploration of the “dark genome.”
September 20, 2023
Dna Genome Gene Targeted Social
NIH to require international collaborators to share all data
Despite concerns from researchers and organizations, the U.S. National Institutes of Health (NIH) will implement its new mandate requiring foreign partners to share raw data and notebooks at regular set intervals with their primary U.S. grant recipients.
September 22, 2023
Lab Scientists Social
Many British health trusts slow to adopt electronic records systems, shows BMJ survey
Many health organizations in England are still reliant on paper patient notes and drug charts, despite progress toward electronic records and prescribing, The BMJ has found.
September 22, 2023
Doctor Fills Patient Medical Record Social